I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Rituximab-PECC induction followed by Y-90-ibritumomab tiuxe..:
Lugtenburg, Pieternella J
;
Zijlstra, Josee M
;
Doorduijn, Jeanette K
...
https://research.rug.nl/en/publications/e3d2d14b-cc0d-4155-b6db-71dade5f8330. , 2019
Link:
https://hdl.handle.net/11370/e3d2d14b-cc0d-4155-b6db-7..
RT Journal T1
Rituximab-PECC induction followed by Y-90-ibritumomab tiuxetan consolidation in relapsed or refractory DLBCL patients who are ineligible for or have failed ASCT:results from a phase II HOVON study
UL https://suche.suub.uni-bremen.de/peid=base-ftunigroningenpu:oai:pure.rug.nl:publications_e3d2d14b-cc0d-4155-b6db-71dade5f8330&Exemplar=1&LAN=DE A1 Lugtenburg, Pieternella J A1 Zijlstra, Josee M A1 Doorduijn, Jeanette K A1 Bohmer, Lara H A1 Hoogendoorn, Mels A1 Berenschot, Henriette W A1 Beeker, Aart A1 van der Burg-de Graauw, Nicole C A1 Schouten, Harry C A1 Bilgin, Yavuz M A1 Kersten, Marie-Jose A1 Koene, Harry R A1 Herbers, Alexandra H. E A1 de Jong, Daphne A1 Hijmering, Nathalie A1 Lam, King H A1 Chitu, Dana A1 Brouwer, Rolf E A1 van Imhoff, Gustaaf W YR 2019 K1 diffuse large B-cell lymphoma K1 relapse K1 Y-90-ibritumomab tiuxetan K1 consolidation K1 PECC K1 B-CELL LYMPHOMA K1 IBRITUMOMAB TIUXETAN K1 ELDERLY-PATIENTS K1 PLUS RITUXIMAB K1 OPEN-LABEL K1 TRIAL K1 CHOP K1 CHEMOTHERAPY K1 MULTICENTER K1 COMBINATION JF https://research.rug.nl/en/publications/e3d2d14b-cc0d-4155-b6db-71dade5f8330 LK http://dx.doi.org/https://hdl.handle.net/11370/e3d2d14b-cc0d-4155-b6db-71dade5f8330 DO https://hdl.handle.net/11370/e3d2d14b-cc0d-4155-b6db-71dade5f8330 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)